Kirklin James K, Naftel David C, Pagani Francis D, Kormos Robert L, Stevenson Lynne W, Blume Elizabeth D, Myers Susan L, Miller Marissa A, Baldwin J Timothy, Young James B
Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
J Heart Lung Transplant. 2015 Dec;34(12):1495-504. doi: 10.1016/j.healun.2015.10.003. Epub 2015 Oct 8.
The seventh annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes the first 9 years of patient enrollment. The Registry includes >15,000 patients from 158 participating hospitals. Trends in device strategy, patient profile at implant and survival are presented. Risk factors for mortality with continuous-flow pumps are updated, and the major causes/modes of death are presented. The adverse event burden is compared between eras, and health-related quality of life is reviewed. A detailed analysis of outcomes after mechanical circulatory support for ambulatory heart failure is presented. Recent summary data from PediMACS and MedaMACS is included. With the current continuous-flow devices, survival at 1 and 2 years is 80% and 70%, respectively.
机构间机械辅助循环支持注册中心（INTERMACS）的第七份年度报告总结了患者入组的前9年情况。该注册中心纳入了来自158家参与医院的15000多名患者。报告呈现了设备策略、植入时患者概况及生存情况的趋势。更新了连续流泵相关的死亡风险因素，并列出了主要死亡原因/方式。比较了不同时期的不良事件负担，并对健康相关生活质量进行了回顾。还对门诊心力衰竭患者接受机械循环支持后的结局进行了详细分析。纳入了儿科机械辅助循环支持注册中心（PediMACS）和孕产妇机械辅助循环支持注册中心（MedaMACS）的近期汇总数据。使用当前的连续流设备，1年和2年生存率分别为80%和70%。
